title: How can we kill cancer cells: Insights from the computational models of apoptosis.
abstract: Cancer cells are widely known to be protected from apoptosis, a phenomenon that is a major hurdle to successful anticancer therapy. Over-expression of several anti-apoptotic proteins, or mutations in pro-apoptotic factors, has been recognized to confer such resistance. Development of new experimental strategies, such as in silico modeling of biological pathways, can increase our understanding of how abnormal regulation of apoptotic pathway in cancer cells can lead to tumour chemoresistance. Monte Carlo simulations are in particular well suited to study inherent variability, such as spatial heterogeneity and cell-to-cell variations in signaling reactions. Using this approach, often in combination with experimental validation of the computational model, we observed that large cell-to-cell variability could explain the kinetics of apoptosis, which depends on the type of pathway and the strength of stress stimuli. Most importantly, Monte Carlo simulations of apoptotic signaling provides unexpected insights into the mechanisms of fractional cell killing induced by apoptosis-inducing agents, showing that not only variation in protein levels, but also inherent stochastic variability in signaling reactions, can lead to survival of a fraction of treated cancer cells.
authors: Subhadip Raychaudhuri, Department of Biomedical Engineering, Biophysics Graduate Group, Graduate Group in Immunology, and Graduate Group in Applied Mathematics, University of California, Davis, CA 95616, United States.
authors: Subhadip
authors: S
authors: Raychaudhuri
references: J Med Chem. 2004 May 6;47(10):2430-40
references: 15115387
references: Biochem Biophys Res Commun. 2003 May 2;304(2):217-22
references: 12711301
references: Leuk Res. 2007 Mar;31(3):277-86
references: 16911824
references: PLoS Biol. 2008 Dec 2;6(12):2831-52
references: 19053173
references: Cancer Cell. 2004 Sep;6(3):241-9
references: 15380515
references: Cancer Cell. 2006 May;9(5):351-65
references: 16697956
references: Nature. 2009 May 21;459(7245):428-32
references: 19363473
references: Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):119-28
references: 15650401
references: Science. 2002 Aug 16;297(5584):1129-31
references: 12183614
references: Leuk Res. 2006 Mar;30(3):322-31
references: 16213584
references: Trends Genet. 1999 Feb;15(2):65-9
references: 10098409
references: Nature. 2009 Feb 19;457(7232):1019-22
references: 19118384
references: Nature. 2006 Nov 30;444(7119):643-6
references: 17122776
references: Apoptosis. 2010 Apr;15(4):401-11
references: 20091232
references: Biophys J. 2008 Oct;95(8):3559-62
references: 18641073
references: J Immunol. 2005 Jul 15;175(2):985-95
references: 16002698
references: Cell Death Differ. 2010 Feb;17(2):278-90
references: 19745831
references: Leukemia. 1995 Jul;9(7):1191-8
references: 7543174
references: Cancer Res. 2006 Mar 1;66(5):2757-64
references: 16510597
references: Br J Haematol. 1995 Oct;91(2):374-9
references: 8547078
references: Apoptosis. 2010 Oct;15(10):1223-33
references: 20563668
references: Science. 2002 Aug 16;297(5584):1183-6
references: 12183631
references: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7124-9
references: 10860979
references: EMBO J. 1998 Mar 16;17(6):1675-87
references: 9501089
references: FEBS Lett. 2001 Jul 13;501(1):79-83
references: 11457460
references: Science. 2005 Oct 7;310(5745):66-7
references: 16210526
references: PLoS One. 2010 Aug 11;5(8):e11930
references: 20711445